Literature DB >> 21327114

Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota.

Inna Sekirov, Navkiran Gill, Maria Jogova, Nicola Tam, Marilyn Robertson, Rosa de Llanos, Yuling Li, Brett B Finlay.   

Abstract

Gastrointestinal infections involve an interactive tripartite relationship between the invading pathogen, the host, and the host's resident intestinal microbiota. To characterize the host inflammatory response and microbiota alterations during enteric salmonellosis, C57BL/6 mice were pre-treated with a low dose of streptomycin (LD model) and then infected with S. typhimurium strains, including mutants in the two Type III secretion systems, SPI-1 and SPI-2 (invAmut and ssaRmut, respectively). Cecal colonization and inflammation in the LD model were evaluated to assess infection success and progression, and compared to the traditional high dose (HD) model. Perturbations to the microbial community in the LD model were assessed via evaluation of total microbial numbers, the proportion of intestinal γ-Proteobacteria and tRFLP analysis. In the LD model, consistently high colonization by the parental strain (WT) and invAmut S. typhimurium was associated with significant intestinal pathology. However, microbial community profiles were more similar both in numbers and composition between mice infected with the mutant strains, than with the WT strain. Consequently, significant infection-induced inflammation did not always produce similar microbiota perturbations. Large numbers of luminal neutrophils were observed in the ceca of WT-infected, but not in invAmut or ssaRmut infected mice. Neutrophils were thus implicated as a potential mediator of microbiota perturbations during WT enteric salmonellosis. These studies offer a new model of S. typhimurium-induced intestinal disease that retains the three participants of the disease process and further defines the role of virulence factors, the host microbiota, and inflammation in S. typhimurium-induced intestinal disease.

Entities:  

Year:  2010        PMID: 21327114      PMCID: PMC3035138          DOI: 10.4161/gmic.1.1.10950

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  36 in total

Review 1.  The Salmonella pathogenicity island-1 type III secretion system.

Authors:  C P Lostroh; C A Lee
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

2.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 3.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms.

Authors:  Siegfried Hapfelmeier; Bärbel Stecher; Manja Barthel; Marcus Kremer; Andreas J Müller; Mathias Heikenwalder; Thomas Stallmach; Michael Hensel; Klaus Pfeffer; Shizuo Akira; Wolf-Dietrich Hardt
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Authors:  Bryan Coburn; Yuling Li; David Owen; Bruce A Vallance; B Brett Finlay
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 7.  Salmonella pathogenicity island 2.

Authors:  M Hensel
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

8.  Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection.

Authors:  Amy Croswell; Elad Amir; Paul Teggatz; Melissa Barman; Nita H Salzman
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

9.  The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Authors:  Jennifer L Bishop; Laura M Sly; Gerald Krystal; B Brett Finlay
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

10.  Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection.

Authors:  Cherilyn D Garner; Dionysios A Antonopoulos; Bettina Wagner; Gerald E Duhamel; Ivan Keresztes; Deborah A Ross; Vincent B Young; Craig Altier
Journal:  Infect Immun       Date:  2009-05-11       Impact factor: 3.441

View more
  32 in total

Review 1.  Regulation of bacterial virulence by Csr (Rsm) systems.

Authors:  Christopher A Vakulskas; Anastasia H Potts; Paul Babitzke; Brian M M Ahmer; Tony Romeo
Journal:  Microbiol Mol Biol Rev       Date:  2015-06       Impact factor: 11.056

Review 2.  The intestinal microbiota and susceptibility to infection in immunocompromised patients.

Authors:  Ying Taur; Eric G Pamer
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

Review 3.  Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis.

Authors:  Triet M Bui; Ronen Sumagin
Journal:  DNA Cell Biol       Date:  2019-06-12       Impact factor: 3.311

Review 4.  Salmonella, the host and its microbiota.

Authors:  Parameth Thiennimitr; Sebastian E Winter; Andreas J Bäumler
Journal:  Curr Opin Microbiol       Date:  2011-10-24       Impact factor: 7.934

5.  Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota.

Authors:  Parameth Thiennimitr; Sebastian E Winter; Maria G Winter; Mariana N Xavier; Vladimir Tolstikov; Douglas L Huseby; Torsten Sterzenbach; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

6.  Use of Attenuated but Metabolically Competent Salmonella as a Probiotic To Prevent or Treat Salmonella Infection.

Authors:  Anice Sabag-Daigle; Henry M Blunk; Juan F Gonzalez; Brandi L Steidley; Prosper N Boyaka; Brian M M Ahmer
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

7.  Salmonella-Mediated Inflammation Eliminates Competitors for Fructose-Asparagine in the Gut.

Authors:  Jikang Wu; Anice Sabag-Daigle; Mikayla A Borton; Linnea F M Kop; Blake E Szkoda; Brooke L Deatherage Kaiser; Stephen R Lindemann; Ryan S Renslow; Siwei Wei; Carrie D Nicora; Karl K Weitz; Young-Mo Kim; Joshua N Adkins; Thomas O Metz; Prosper Boyaka; Venkat Gopalan; Kelly C Wrighton; Vicki H Wysocki; Brian M M Ahmer
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

8.  Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis.

Authors:  Sara Gaines; Sanjiv Hyoju; Ashley J Williamson; Jasper B van Praagh; Olga Zaborina; David T Rubin; John C Alverdy; Benjamin D Shogan; Neil Hyman
Journal:  J Gastrointest Surg       Date:  2020-01-02       Impact factor: 3.452

9.  The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner.

Authors:  Benoit Raymond; Valerie F Crepin; James W Collins; Gad Frankel
Journal:  Cell Microbiol       Date:  2011-09-14       Impact factor: 3.715

10.  Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth.

Authors:  Caroline C Gillis; Elizabeth R Hughes; Luisella Spiga; Maria G Winter; Wenhan Zhu; Tatiane Furtado de Carvalho; Rachael B Chanin; Cassie L Behrendt; Lora V Hooper; Renato L Santos; Sebastian E Winter
Journal:  Cell Host Microbe       Date:  2017-12-21       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.